Mutational Signature Indicates Risk of Kidney Cancer Recurrence
Mutational Signature Indicates Risk of Kidney Cancer Recurrence
DNA sequencing can identify mutations that predict recurrence of renal cell carcinoma and may help low-risk patients avoid unnecessary treatment, a study finds.
DNA sequencing can identify mutations that predict recurrence of renal cell carcinoma and may help low-risk patients avoid unnecessary treatment, a study finds.
von Hippel-Lindau
Cells’ Oxygen Sensing Discovery Earns Nobel Prize
Emily Makowski | Oct 7, 2019 | 2 min read
For the Physiology or Medicine award, Peter Ratcliffe, William Kaelin, and Gregg Semenza are credited with figuring out molecular and genetic responses to oxygen levels.